Vandortuzumab
Vandortuzumab is a CHO-expressed humanized antibody targeting STEAP1. Vandortuzumab has a huIgG1 type heavy chain and a huκ type light chain, with a predicted molecular weight (MW) of 145.5 kDa. The isotype control for Vandortuzumab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001) .
Product Specifications
Product Name Alternative
DSTP-3086S Antibody; RG-7450 Antibody
UNSPSC
12352203
Target
Transmembrane Glycoprotein
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/vandortuzumab.html
Purity
99.00
Molecular Weight
(145.5 kDa)
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
038515-APC 200 µL
MMRN2, CT (MMRN2, EMILIN3, Multimerin-2, EMILIN-3, Elastin microfibril interface located protein 3, EndoGlyx-1 p125/p140 subunit) (APC) discontinued
Sign In for Pricing
View Details 
042650-APC 200 µL
TBCE, ID (TBCE, Tubulin-specific chaperone E, Tubulin-folding cofactor E) (APC) discontinued
Sign In for Pricing
View Details MBS7199333 Inquire
Rabbit anti-Human immunodeficiency virus type 1 group M subtype B (strain 89.6)(HIV-1) VPR Polyclonal Antibody
Sign In for Pricing
View Details 584741-01 20 µg
Granulocyte-macrophage Colony-stimulating Factor, Recombinant, Human, aa18-144, His-Tag
Sign In for Pricing
View Details